Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481013 · ClinicalTrials.gov registry record · Phase 2
Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT00481013 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 33 participants.
The verdict
NCT00481013, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
The primary objective of this proposal is to determine whether oral VPA is effective in treating SMA in adult patients.
Interventions
- DRUG Placebo
- DRUG Valproic Acid (VPA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00481013
The ClinicalTrials.gov registry entry for NCT00481013 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00481013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00481013 about?
NCT00481013 is a clinical study titled "Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy". The primary objective of this proposal is to determine whether oral VPA is effective in treating SMA in adult patients.
What is the current status of trial NCT00481013?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2007-07. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00481013?
The interventions under investigation include: Placebo (DRUG), Valproic Acid (VPA) (DRUG).
Who is sponsoring clinical trial NCT00481013?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.